Abstract
Galanthus nivalis agglutinin (GNA)-related lectin family, a superfamily of strictly mannose-binding specific lectins widespread among monotyledonous plants, is well-known to possess a broad range of biological functions such as anti-tumor, anti-fungal and anti-viral activities. Growing insights into the investigations of them provide us a principal force to start this review with a variety of evidences to landmark their biological activities, molecular mechanisms and potential therapeutic applications. Herein, we mainly focused on a comprehensive study on a great number of reported GNA-related lectins with the anti-tumor activity. On the trail of such clues, we studied some GNA-related lectins with anti-tumor effects and explored the apoptosis- and autophagy-induced activities and related molecular mechanisms. These inspiring results further provide us more convincing evidence to understand the anti-cancer molecular mechanisms implicated in apoptosis and autophagy. In addition, GNA-related lectins also possess marked anti-HIV activities and the specific molecular mechanisms are also explored herein. To sum up, GNA-related lectin family would play a key role as a potential drug in future therapeutics.
Keywords: GNA-related lectins, anti-tumor activity, apoptosis, autophagy, drug
Current Chemical Biology
Title: Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?
Volume: 3 Issue: 3
Author(s): Chun-yang Li, Liang Meng, Bo Liu and Jin-ku Bao
Affiliation:
Keywords: GNA-related lectins, anti-tumor activity, apoptosis, autophagy, drug
Abstract: Galanthus nivalis agglutinin (GNA)-related lectin family, a superfamily of strictly mannose-binding specific lectins widespread among monotyledonous plants, is well-known to possess a broad range of biological functions such as anti-tumor, anti-fungal and anti-viral activities. Growing insights into the investigations of them provide us a principal force to start this review with a variety of evidences to landmark their biological activities, molecular mechanisms and potential therapeutic applications. Herein, we mainly focused on a comprehensive study on a great number of reported GNA-related lectins with the anti-tumor activity. On the trail of such clues, we studied some GNA-related lectins with anti-tumor effects and explored the apoptosis- and autophagy-induced activities and related molecular mechanisms. These inspiring results further provide us more convincing evidence to understand the anti-cancer molecular mechanisms implicated in apoptosis and autophagy. In addition, GNA-related lectins also possess marked anti-HIV activities and the specific molecular mechanisms are also explored herein. To sum up, GNA-related lectin family would play a key role as a potential drug in future therapeutics.
Export Options
About this article
Cite this article as:
Li Chun-yang, Meng Liang, Liu Bo and Bao Jin-ku, Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?, Current Chemical Biology 2009; 3 (3) . https://dx.doi.org/10.2174/2212796810903030324
DOI https://dx.doi.org/10.2174/2212796810903030324 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PET Imaging of Beta-Adrenoceptors in Human Brain: A Realistic Goal or a Mirage?
Current Pharmaceutical Design Therapeutic Applications of Calcium Metabolism Modulation in Heart Disease
Medicinal Chemistry The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?
Current Pharmaceutical Design Tandem Mass Spectrometry Newborn Screening for Inborn Errors of Intermediary Metabolism: Abnormal Profile Interpretation
Current Medicinal Chemistry Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design Progress in Imaging Agents of Cell Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Current Cardiology Reviews Biological Actions and Metabolism of Currently Used Pharmacological Agents for the Treatment of Congestive Heart Failure
Current Drug Metabolism Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?
Current Hypertension Reviews Chronic Complications of Diabetes Mellitus: A Mini Review
Current Diabetes Reviews Dipyridamole: A Drug with Unrecognized Antioxidant Activity
Current Topics in Medicinal Chemistry Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update
Current Medicinal Chemistry Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Current Gene Therapy New Targeted Therapies for Thyroid Cancer
Current Genomics Angiotensin Receptor Blockers in Chronic Heart Failure: Clinical Implications and Molecular Mechanisms
Current Cardiology Reviews Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study
Current Pharmaceutical Design High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design Drugs Targeting Parasite Lysosomes
Current Pharmaceutical Design Endoplasmic Reticulum Stress as a Novel Therapeutic Target in Heart Diseases
Cardiovascular & Hematological Disorders-Drug Targets